Terms ending in 2040
Every in-force patent on Translate Bio, Inc.'s record whose computed term ends in 2040, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 12,370,238 | Composition and Methods for Treatment of Primary Ciliary Dyskinesia In force · High confidence | Translate Bio, Inc. | In force | High confidence | |
| US 11,357,726 | Process of Preparing Mrna-Loaded Lipid Nanoparticles In force · High confidence | Translate Bio, Inc. | In force | High confidence | |
| US 11,174,500 | Methods for Purification of Messenger RNA In force · High confidence | Translate Bio, Inc. | In force | High confidence | |
| US 12,201,677 | Messenger RNA Therapy for the Treatment of Ornithine Transcarbamylase Deficiency In force · High confidence | Translate Bio, Inc. | In force | High confidence | |
| US 12,084,702 | Methods for Purification of Messenger RNA In force · High confidence | Translate Bio, Inc. | In force | High confidence | |
| US 12,370,262 | Messenger RNA Vaccines and Uses Thereof In force · High confidence | Translate Bio, Inc. | In force | High confidence | |
| US 11,559,561 | Composition and Methods for Treatment of Primary Ciliary Dyskinesia In force · High confidence | Translate Bio, Inc. | In force | High confidence | |
| US 12,318,489 | Nanoparticle Formulations for Delivery of Nucleic Acid Complexes In force · High confidence | Translate Bio MA, Inc. | In force | High confidence | |
| US 11,453,877 | Methods for Purification of Messenger RNA In force · High confidence | Translate Bio, Inc. | In force | High confidence | |
| US 12,195,505 | TREATMENT OF CYSTIC FIBROSIS BY DELIVERY OF NEBULIZED mRNA ENCODING CFTR In force · High confidence | Translate Bio, Inc. | In force | High confidence | |
| 4 more term ends in 2040 · Pro | |||||
10 of 14 patents shown. Soonest term end first, then patent number.
Pro members see all 14.
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.